Goldman Sachs Raises Price Target on Onyx Pharma (ONXX) after FDA Panel Backs CFZ
Go back to Goldman Sachs Raises Price Target on Onyx Pharma (ONXX) after FDA Panel Backs CFZ| Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) | Delayed: 124.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.70 | 52 Week High | $136.87 | |||
| Open | $124.70 | 52 Week Low | $68.12 | |||
| Day High | $124.70 | P/E | N/A | |||
| Day Low | $124.70 | EPS | $-1.58 | |||
| Volume | 514,854 | |||||
